Covered recipient · General Payments record
OMEED MODIRI
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2024
$950.24
- Reported across 10 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $950.24 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $245.53 | 2 |
| ABBVIE INC. | $211.12 | 3 |
| Dermavant Sciences, Inc. | $199.22 | 2 |
| UCB, Inc. | $188.57 | 2 |
| Almirall LLC | $105.80 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $950.24 | 10 |
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $78.71 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105049640 | CMS |
| ABBVIE INC. | $127.51 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105049642 | CMS |
| ABBVIE INC. | $4.90 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105049644 | CMS |
| Almirall LLC | $105.80 | 06/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120641062 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $124.40 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117988242 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $121.13 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117988240 | CMS |
| Dermavant Sciences, Inc. | $114.40 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127908220 | CMS |
| Dermavant Sciences, Inc. | $84.82 | 11/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127908224 | CMS |
| UCB, Inc. | $49.68 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143435275 | CMS |
| UCB, Inc. | $138.89 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143435279 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.